Facebook Pixel Code
Labatt Family Heart Centre
Labatt Family Heart Centre

Funding opportunities

Labatt Heart Centre Innovation Funds

The Heart Centre Innovation Fund (IF) was established in 2007 as part of the $10M Labatt Family Endowment. Deadlines are in April and November each year. The fund supports projects that require start-up funds for basic research, clinical research, or quality improvement projects that impact cardiac patients.  

Recent funded projects.

The application can be found here.

The next deadline for submissions will be Monday April 16, 2018

Eligible Applicants:

The Innovation Fund is open on a competitive basis to researchers and clinicians within the Labatt Family Heart Centre. 

External applicants are eligible to apply however, the applicant must have a collaborator who is affiliated with the Heart Centre and also the project should have direct impact to Cardiology patients.

Funding provided:

Up to $25,000 is available for each award.
 

Project duration should be no longer than two years.

Allocation of Funds

The ability to measure a successful outcome is crucial to the assessment of your application.

Funds will be awarded only if the applicant’s proposal is in alignment with the future directions (link) of the Heart Centre.

Evaluation Criteria

Innovation:  

  • Proposed work represents novel, unique, high risk concepts and creative thinking.

Potential for future development / dissemination:  

  • Proposed research represents work that will lead to future expansion.  
  • For research, is this an important proof of concept or pilot work that will lead to new research directions or larger funding applications or development of new research teams?  
  • For clinical, is this a program that might be applied in other settings and other centres and achieve wider dissemination?
  • For education, is this a program that can be disseminated or expanded?

Measures of impact:  This is perhaps the most important criteria. 

  • How will the work impact its intended target or field of inquiry?  
  • Measures must be clearly delineated and specific to the proposed work.

Quality of the proposal:

  • Is the proposal well-organized and written?
  • Are the purposes or aims of the work clearly specified?
  • Is the work to be performed clearly described? 
  • Is there a rigorous and relevant evaluation of outcomes? 
  • Is the work scientifically sound?

Feasibility:

  • Can the work proposed be successfully performed given the expertise and resources available and requested?

Applicants:

  • Do the applicants have sufficient expertise, experience and motivation to perform and report the work?

Budget:

  • Is the budget sufficient to perform the work proposed successfully?
  • Is the budget reasonable and well justified?  

Review Committee Members

Review members commit to a 3 year term and review the applications twice per year.  The reviews come from the departments of Cardiovascular Surgery, Nursing, Critical Care Medicine, the Research Institute, and Cardiology.

 

Congratulations to the following applicants who were successfully funded in 2017.

  1. Chris Caldarone and Rachel Vanderlaan:  Linking genetic candidates to pulmonary vein biology: the role of primary cilia in pathophysiology of pulmonary vein stenosis   $24,220
  2. Nita Chahal:  Parents and Adolescents Living with Kawasaki Disease with Coronary Artery Aneurysms: Educational and Psychosocial Needs Assessment  $24,800
  3. Vann Chau, Torin Glass and Mike Seed:  IGF-1 and Brain growth in Congenital Heart Disease  $25,000
  4. Christoph Haller and Osami Honjo:  Closed-circuit ex-vivo perfusion of the heart in a porcine DCD transplant setting  $21,527
  5. Brian McCrindle and Michael Khoury:  Lifestyle behaviours and cardiometabolic risk in children: evaluating changes and associations that occur from childhood to adolescence  $24,940
  6. Glen Van Arsdell:  High intensity focused ultrasound histotripsy to treat congenital cardiac disease   $25,000
  7. Lynne Nield and Andrea Pisesky:  The prevalence and morbidity of ciliary genetic mutations in patients with specific congenital heart disease phenotypes - a cohort study  $10,000
  8. Katherine Taylor:  Inflammatory Biomarkers in Pediatric Pulmonary Hypertension: A Prospective Cohort Study  $12,153
  9. Edgar Jaeggi:  Correlation between Maternal anti-Ro-60 Antibody-Titers and Fetal Manifestations of Cardiac Neonatal Lupus (NLE)  $10,800
  10. Peter Laussen and Azadeh Assadi:  Development of MyHeartPass  $23,866